Related and Nonrelated Parties [Axis] Sanovas Ophthalmology LLC [Member] Related Party [Member] Class of Stock [Axis] Series F Preferred Stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Stock Subscription Receivable [Member] Retained Earnings [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Pre-funded Warrant [Member] Warrant [Member] Title and Position [Axis] Officer [Member] Statistical Measurement [Axis] Minimum [Member] Plan Name [Axis] 2017 Equity Incentive Plan [Member] Stock Option One [Member] Stock Option Two [Member] Vesting [Axis] Vesting Over One Year [Member] Vesting Over Two Year [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Employment Agreement [Member] Maximum [Member] Exchange Agreement [Member] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Measurement Input, Share Price [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current Assets Cash Total Current Assets Operating lease right-of-use asset Security deposit TOTAL ASSETS LIABILITIES AND STOCKHOLDER’S DEFICIT Liabilities Current Liabilities Accounts payable and accrued liabilities Due to related parties Shareholders’ notes payable Operating lease liability – current portion Accrued interest payable Total Current Liabilities Operating lease liability – long term portion Total liabilities Stockholder’s Deficit: Preferred stock, $0.0001 par value; 40,000,000 shares authorized; Series F preferred stock - 3,000,000 shares designated, 0 issued and outstanding at March 31, 2026 and December 31, 2025 Common stock, $0.0001 par value; 80,000,000 shares authorized; 18,754,739 shares issued and outstanding at March 31, 2026 and December 31, 2025 Additional paid-in capital Stock subscription receivable Accumulated deficit Total Stockholders’ Deficit TOTAL LIABILITIES AND STOCKHOLDER’S DEFICIT Statement [Table] Statement [Line Items] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating expenses: General and administrative Research and development Stock-based compensation Total operating expenses Interest expense, net Net loss Net loss per share - basic Net loss per share - diluted Weighted average number of common shares outstanding during the period- basic Weighted average number of common shares outstanding during the period- diluted Balance Balance, shares Collection of stock subscription receivable Stock based compensation expense Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows From Operating Activities Adjustments to reconcile net loss to net cash (used in) operating activities Non-cash items: Stock-based compensation expense Depreciation expense Amortization of ROU asset Expenses allocated by Sanovas on behalf of Company Changes in operating liabilities: Increase in accounts payable and accrued liabilities Decrease in lease liability Increase in accrued interest Total adjustments Net cash (used in) operating activities Cash Flows From Financing Activities Proceeds from collection of stock subscription receivable Proceeds from exercise of stock options and warrants Advances from related parties, net Net cash provided by financing activities Net (decrease) in cash Cash at beginning of period Cash at end of period Supplemental Disclosure of Cash Flow information: Interest paid during the period Income taxes paid during the period Accounting Policies [Abstract] HISTORY, BUSINESS PURPOSE, LIQUIDITY AND GOING CONCERN SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] COMMON AND PREFERRED STOCK STOCK PLAN Warrants WARRANTS Debt Disclosure [Abstract] SHAREHOLDERS’ NOTES PAYABLE Lease LEASE Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation and Consolidation Cash Equivalents Use of Estimates Income Taxes Income (Loss) Per Common Share Stock-based compensation Research and Development costs Property and Equipment Leases Segment Reporting Recent Accounting Pronouncements SCHEDULE OF RELATED PARTY TRANSACTIONS SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF WARRANTS FAIR VALUE ASSUMPTIONS SCHEDULE OF LEASE LIABILITY MATURITY SCHEDULE OF LEASE-RELATED ASSETS AND LIABILITIES Accumulated deficit Liabilities Due to related party Number of shares sold Sale of stock, price per share Gross proceeds Stock subscribed Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities excluded from computation of loss per share Property and equipment, Estimated useful lives Related Party Transaction [Table] Related Party Transaction [Line Items] Balance due to Sanovas – beginning of period Costs of Sanovas allocated to the Company Cash advances (repayments) from Sanovas to the Company, net Balance due to Sanovas - end of period Costs and expenses Advance funds received Stock, Class of Stock [Table] Class of Stock [Line Items] Preferred stock shares authorized Share offering price Collection of stock subscription receivable Preferred stock, voting right Preferred stock, protective features Preferred stock, dividend Preferred stock conversion basis Preferred stock conversion terms Proceeds from issuance of preferred stock Options Issued, Options outstanding, beginning balance Weighted-Average Exercise Price, Options outstanding beginning balance Options Issued, Granted Weighted-Average Exercise Price, Granted Options Issued, Canceled Weighted-Average Exercise Price, Canceled Options Issued, Forfeited Weighted-Average Exercise Price, Forfeited Options Issued, Exercised Weighted-Average Exercise Price, Exercised Options Issued, Options outstanding, ending balance Weighted-Average Exercise Price, Options outstanding ending balance Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Exercise Price Number Outstanding Weighted Average Remaining Contractual Life Number Exercisable Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock shares reserved for future issuance Stock option expense Shares available for issuance Class of Warrant or Right [Table] Warrant issued to purchase common stock Warrant exercise price Warrants vesting shares Potentially issuable warrants vesting shares Additional warrants to purchase shares Fair value of warrants grant price per share Expected dividend yield Unrecognized compensation expense Weighted-average period for recognition Common stock exchanged for warrants Schedule Of Warrants Activity Warrants Issued, Warrants outstanding, Beginning balance Weighted-Average Exercise Price, Warrants outstanding, Beginning balance Warrants Issued, Granted Weighted-Average Exercise Price, Granted Warrants Issued, Canceled and expired Weighted-Average Exercise Price, Canceled and expired Warrants Issued, Exercised Weighted-Average Exercise Price, Exercised Warrants Issued, Warrants outstanding, Ending balance Weighted-Average Exercise Price, Warrants outstanding, Ending balance ScheduleOfWarrantsOutstandingTable [Table] Exercise Price Number Outstanding Weighted Average Remaining Contractual Life Number Exercisable Business Combination [Table] Business Combination [Line Items] Warrant measurement input Debt instrument, face amount Interest rate Notes payable Interest expense Accrued interest Schedule Of Lease Liability Maturity 2026 (remainder of year) 2027 Total payments Less interest Total liability Schedule Of Lease-related Assets And Liabilities Right-of-use asset, net Lease liability -long term portion Lease liability – current portion Lease description Operating lease term Security deposit Discount rate Lease payments Lease payments per month Lease payments over month Lease payments term Subsequent Event [Table] Subsequent Event [Line Items] Sale of stock, shares Sale of shares, price per share Stock Subscription Receivable [Member] Sanovas Ophthalmology LLC [Member]. Pre-funded Warrant [Member] Costs of related party allocated. 2017 Equity Incentive Plan [Member]. Stock Option One [Member] Stock Option Two [Member] Warrants Disclosure [Text Block] Vesting Over One Year [Member] Vesting Over Two Year [Member] Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price granted. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price cancelled. Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price exercised. Schedule of Warrant Outstanding [Table Text Block] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms. Share based compensation arrangement by share based payment award non option equity instruments exercisableNumber. Schedule of share based payment award warrants valuation assumptions. Exchange Agreement [Member] Schedule of Lease Related Assets And Liabilities [Table Text Block] Employment Agreement [Member] Collection of stock subscription receivable. Assets, Current Assets Liabilities, Current Liabilities [Default Label] Stockholders' Equity Note, Subscriptions Receivable Equity, Attributable to Parent Liabilities and Equity Operating Expenses Shares, Outstanding Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Compensation Related Costs, Policy [Policy Text Block] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber Lessee, Operating Lease, Liability, to be Paid Operating Lease, Liability Lease Deposit Liability